Yu SS - Search Results

1

Construction of retroviral vectors with improved safety, gene expression, and versatility.

Kim SH, Yu SS, Park JS, Robbins PD, An CS, Kim S. Kim SH, et al. Among authors: yu ss. J Virol. 1998 Feb;72(2):994-1004. doi: 10.1128/JVI.72.2.994-1004.1998. J Virol. 1998. PMID: 9444992 Free PMC article.

2

Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein.

Kim S, Yu SS, Kim VN. Kim S, et al. Among authors: yu ss. J Gen Virol. 1996 Jan;77 ( Pt 1):83-91. doi: 10.1099/0022-1317-77-1-83. J Gen Virol. 1996. PMID: 8558131

3

Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.

Byun J, Kim SH, Kim JM, Yu SS, Robbins PD, Yim J, Kim S. Byun J, et al. Among authors: yu ss. Gene Ther. 1996 Sep;3(9):780-8. Gene Ther. 1996. PMID: 8875226

4

Human cytomegalovirus IE1 protein activates AP-1 through a cellular protein kinase(s).

Kim S, Yu SS, Lee IS, Ohno S, Yim J, Kim S, Kang HS. Kim S, et al. Among authors: yu ss. J Gen Virol. 1999 Apr;80 ( Pt 4):961-969. doi: 10.1099/0022-1317-80-4-961. J Gen Virol. 1999. PMID: 10211966

5

High efficiency retroviral vectors that contain no viral coding sequences.

Yu SS, Kim JM, Kim S. Yu SS, et al. Gene Ther. 2000 May;7(9):797-804. doi: 10.1038/sj.gt.3301164. Gene Ther. 2000. PMID: 10822307

6

Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases.

Lee Y, Park EJ, Yu SS, Kim DK, Kim S. Lee Y, et al. Among authors: yu ss. Biochem Biophys Res Commun. 2000 May 27;272(1):230-5. doi: 10.1006/bbrc.2000.2758. Biochem Biophys Res Commun. 2000. PMID: 10872832

7

The 17 nucleotides downstream from the env gene stop codon are important for murine leukemia virus packaging.

Yu SS, Kim JM, Kim S. Yu SS, et al. J Virol. 2000 Sep;74(18):8775-80. doi: 10.1128/jvi.74.18.8775-8780.2000. J Virol. 2000. PMID: 10954583 Free PMC article.

8

Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.

Kim JM, Ho SH, Hahn W, Jeong JG, Park EJ, Lee HJ, Yu SS, Lee CS, Lee YW, Kim S. Kim JM, et al. Among authors: yu ss. Gene Ther. 2003 Aug;10(15):1216-24. doi: 10.1038/sj.gt.3301985. Gene Ther. 2003. PMID: 12858186

9

Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist.

Kim JM, Jeong JG, Ho SH, Hahn W, Park EJ, Kim S, Yu SS, Lee YW, Kim S. Kim JM, et al. Among authors: yu ss. Gene Ther. 2003 Sep;10(18):1543-50. doi: 10.1038/sj.gt.3302042. Gene Ther. 2003. PMID: 12907945

10

Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector.

Lee JT, Yu SS, Han E, Kim S, Kim S. Lee JT, et al. Among authors: yu ss. Gene Ther. 2004 Jan;11(1):94-9. doi: 10.1038/sj.gt.3302138. Gene Ther. 2004. PMID: 14681702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,216 results

Search Page

Filters